Mettler Toledo International (MTD) Non-Current Deferred Tax Liability (2009 - 2026)
Mettler Toledo International (MTD) posted quarterly Non-Current Deferred Tax Liability of $145.5 million for Q2 2026, up 26.44% year-over-year from $115.1 million in Q2 2025, and down 1.27% on a QoQ basis from $147.4 million in Q1 2026.
Mettler Toledo International (MTD) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
Mettler Toledo International has reported Non-Current Deferred Tax Liability for 18 years, with the latest figure at $145.5 million in Q2 2026.
- Non-Current Deferred Tax Liability for Q2 2026 came in at $145.5 million, up 26.44% year-over-year; the trailing twelve-month figure through Jun 2026 was $145.5 million (up 26.44% YoY), and the FY2025 annual result was $151.8 million, down 41.07% from the prior year.
- Non-Current Deferred Tax Liability eased to $145.5 million in Q2 2026, from $147.4 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $265.3 million in Q4 2022 and troughed at $65.2 million in Q1 2022.
- A 5-year average of $134.3 million and a median of $112.8 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- The widest annual swing landed in 2022, when Non-Current Deferred Tax Liability surged 92.71%; it then plunged 41.07% in 2025.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $265.3 million in 2022, then fell by 1.58% to $261.1 million in 2023, then declined by 1.36% to $257.6 million in 2024, then plunged by 41.07% to $151.8 million in 2025, then slipped by 4.13% to $145.5 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $145.5 million in Q2 2026, $147.4 million in Q1 2026, and $151.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 145.51 Mn |
| Jun 30, 2026 | 145.51 Mn |
| Mar 31, 2026 | 147.39 Mn |
| Mar 31, 2026 | 147.39 Mn |
| Dec 31, 2025 | 151.78 Mn |
| Dec 31, 2025 | 151.78 Mn |
| Sep 30, 2025 | 108.04 Mn |
| Sep 30, 2025 | 108.04 Mn |
| Jun 30, 2025 | 115.09 Mn |
| Jun 30, 2025 | 115.09 Mn |
| Mar 31, 2025 | 103.86 Mn |
| Mar 31, 2025 | 103.86 Mn |
| Dec 31, 2024 | 103.95 Mn |
| Dec 31, 2024 | 103.95 Mn |
| Sep 30, 2024 | 107.74 Mn |
| Sep 30, 2024 | 107.74 Mn |
| Jun 30, 2024 | 101.74 Mn |
| Jun 30, 2024 | 101.74 Mn |
| Mar 31, 2024 | 100.12 Mn |
| Mar 31, 2024 | 100.12 Mn |